Published in Medical Letter on the CDC and FDA, February 5th, 2006
Vivaglobin, manufactured by ZLB Behring GmbH of Marburg, Germany, from human plasma collected at U.S. licensed plasma centers, provides new delivery options for PIDD patients. It is given under the skin (subcutaneously) on a weekly basis using an infusion pump, which means patients can self-administer the product at home. Some patients develop problems that make chronic intravenous administration of needed medicines...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA